Search Results

You are looking at 181 - 190 of 496 items for :

  • "adjuvant chemotherapy" x
  • Refine by Access: All x
Clear All
Full access

Angela M. Davies, Philip C. Mack, Primo N. Lara Jr., Derick H. Lau, Kathleen Danenberg, Paul H. Gumerlock, and David R. Gandara

advanced or metastatic NSCLC . J Clin Oncol 2003 ; 21 : 2658 – 2663 . 36 Mitsudomi T Yatabe Y Tada H . Lack of predictive value of p53, p27, Bcl2, HER2/neu, EGFR alterations for efficacy of postoperative adjuvant chemotherapy consisting of

Full access

Ronald C. Chen, William U. Shipley, Jason A. Efstathiou, and Anthony L. Zietman

cystectomy and adjuvant chemotherapy . Urology 2009 ; 73 : 833 – 837 . 28. Hagan MP Winter KA Kaufman DS . RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation

Full access

continuum of care in metastatic colorectal cancer have resulted in a major improvement in median survival compared with 1996, and adjuvant chemotherapy for stage III colon cancer with FOLFOX and CapeOx has also improved survival. Further, discovery of

Full access

Joseph A. Roscoe, Gary R. Morrow, Jane T. Hickok, Karen M. Mustian, and Abhay R. Shelke

-Trill M Hakes TB Kaufman RJ . Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer . Cancer 1988 ; 61 : 379 – 385 . 13 Haut MW Beckwith B Laurie JA Klatt N . Postchemotherapy

Full access

chemotherapy is preferred for these patients to aid resectability. If IORT is not available, additional 10-20 Gy external beam radiation and/or brachytherapy could be considered to a limited volume. The ending of “prior to adjuvant chemotherapy” removed

Full access

Brigette A. Davis, Jenerius A. Aminawung, Maysa M. Abu-Khalaf, Suzanne B. Evans, Kevin Su, Rajni Mehta, Shi-Yi Wang, and Cary P. Gross

-related genes and 5 reference genes) to generate a recurrence score (RS). Studies have shown that the RS is both prognostic—it correlates with 10-year risk of distant recurrence—and predictive of the degree to which adjuvant chemotherapy will reduce the risk of

Full access

Sheshadri Madhusudhana, Michelle Gates, Daulath Singh, Punita Grover, Mahathi Indaram, and An-Lin Cheng

new cancer diagnosis and a curative-intent treatment plan including adjuvant chemotherapy, definitive chemotherapy, or definitive CRT were selected for study inclusion. Eligible diagnoses were lymphoma (stage I–IV), solid tumor malignancy after

Full access

Ann Malone Berger and Sandra A. Mitchell

(Suppl 2) : 72 – 77 . 37. de Jong N Courtens AM Abu-Saad HH . Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature . Cancer Nurs 2002 ; 25 : 283 – 297 ; quiz 298–289 . 38. Donovan KA

Full access

Melinda L. Telli and Ronald M. Witteles

years of adjuvant trastuzumab monotherapy initiated after the completion of (neo)adjuvant chemotherapy and adjuvant radiotherapy versus observation. BCIRG 006 (n = 3222) contained 3 arms, including AC followed by docetaxel, with or without 1 year of

Full access

Benjamin E. Greer, Wui-Jin Koh, Nadeem Abu-Rustum, Michael A. Bookman, Robert E. Bristow, Susana M. Campos, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Patricia J. Eifel, Warner K. Huh, Wainwright Jaggernauth, Daniel S. Kapp, John J. Kavanagh, John R. Lurain III, Mark Morgan, Robert J. Morgan Jr, C. Bethan Powell, Steven W. Remmenga, R. Kevin Reynolds, Angeles Alvarez Secord, William Small Jr, and Nelson Teng

radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study . Gynecol Oncol 2008 ; 108 : 226 – 233 . 55 Hogberg T . Adjuvant chemotherapy